Cargando…

Beta-Blocker Use after Discharge in Patients with Acute Myocardial Infarction in the Contemporary Reperfusion Era

Background and objectives: The effect of beta-blocker use after discharge on patients with acute myocardial infarction (AMI) in the contemporary reperfusion era remains ambiguous. By applying meta-analysis, we sought to assess the role of beta-blockers in the contemporary reperfusion era. Materials...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Mengjin, Hu, Song, Gao, Xiaojin, Yang, Yuejin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506114/ https://www.ncbi.nlm.nih.gov/pubmed/36143854 http://dx.doi.org/10.3390/medicina58091177

Ejemplares similares

The Optimal Strategy of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stent
por: Hu, Mengjin, et al.
Publicado: (2022)

Short- and Long-Term Outcomes in Patients With Right Ventricular Infarction According to Modalities of Reperfusion Strategies in China: Data From China Acute Myocardial Infarction Registry
por: Hu, Mengjin, et al.
Publicado: (2022)

Atrioventricular block after reperfusion: A reflection on early beta-blocker therapy for acute myocardial infarction
por: Zhong, Yue, et al.
Publicado: (2017)

Comparison of Six Different Percutaneous Coronary Intervention Guidance Modalities
por: Hu, Mengjin, et al.
Publicado: (2022)

Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023)

Clinical Outcomes of Calcium-Channel Blocker vs Beta-Blocker: From the Korean Acute Myocardial Infarction Registry
por: Kim, Moo Hyun, et al.
Publicado: (2023)

Should We Be Using Upstream Beta-Blocker Therapy for Acute Myocardial Infarction?
por: Giannakopoulos, Georgios, et al.
Publicado: (2021)

Beta-blocker therapy in patients with acute myocardial infarction: not all patients need it
por: Joo, Seung-Jae
Publicado: (2023)

Atrial fibrillation in patients hospitalized with acute myocardial infarction: analysis of the china acute myocardial infarction (CAMI) registry
por: Dai, Yan, et al.
Publicado: (2017)

Use of Mendelian randomization to evaluate the effect of atrial fibrillation on cardiovascular diseases and cardiac death
por: Hu, Mengjin, et al.
Publicado: (2022)

The Comparison of the Outcomes between Primary PCI, Fibrinolysis, and No Reperfusion in Patients ≥ 75 Years Old with ST-Segment Elevation Myocardial Infarction: Results from the Chinese Acute Myocardial Infarction (CAMI) Registry
por: Peiyuan, He, et al.
Publicado: (2016)

Beta-Blocker Therapy Early After Myocardial Infarction: A Comparison Between Medication at Hospital Discharge and Subsequent Pharmacy-Dispensed Medication
por: Pedersen, Susanne Bendesgaard, et al.
Publicado: (2016)

Causal Associations between Paternal Longevity and Risks of Cardiovascular Diseases
por: Hu, Mengjin, et al.
Publicado: (2022)

Beta-blockers and renin-angiotensin system inhibitors in acute myocardial infarction managed with inhospital coronary revascularization
por: Sim, Hui Wen, et al.
Publicado: (2020)

One‐Year Landmark Analysis of the Effect of Beta‐Blocker Dose on Survival After Acute Myocardial Infarction
por: Goldberger, Jeffrey J., et al.
Publicado: (2021)

The Relationship Between Body Mass Index and In-Hospital Mortality in the Contemporary Era of an Acute Myocardial Infarction Management
por: Elbaz-Greener, Gabby, et al.
Publicado: (2021)

Prognostic Implications of High-Degree Atrio-Ventricular Block in Patients with Acute Myocardial Infarction in the Contemporary Era
por: Velásquez-Rodríguez, Jesús, et al.
Publicado: (2023)

Reperfusion injury in acute myocardial infarction
por: Simonis, Gregor, et al.
Publicado: (2012)

Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2020)

Clinical Impact of Beta-blockers in the Revascularization Era
por: Kang, Soo-Jin
Publicado: (2020)

Beta Blocker Use After Acute Myocardial Infarction in the Patient with Normal Systolic Function: When is it “Ok” to Discontinue?
por: Kezerashvili, Anna, et al.
Publicado: (2012)

Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI)
por: Yndigegn, Troels, et al.
Publicado: (2022)

Beta blockers in traumatic brain injury: a systematic review and meta-analysis
por: Hart, Shannon, et al.
Publicado: (2023)

Beta-Blockers for the Secondary Prevention of Myocardial Infarction in People with Dementia: A Systematic Review
por: Lanham, David, et al.
Publicado: (2019)

Usefulness of universal beta-blocker therapy in patients after ST-elevation myocardial infarction
por: Ferreira, João André, et al.
Publicado: (2021)

Should beta‐blockers be continued as a treatment for myocardial infarction in the case of Kounis syndrome?
por: Amino, Mari, et al.
Publicado: (2021)

Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes
por: Ishak, Divan, et al.
Publicado: (2023)

Machine learning for prediction of bleeding in acute myocardial infarction patients after percutaneous coronary intervention
por: Zhao, Xueyan, et al.
Publicado: (2023)

Development and validation of dynamic models to predict postdischarge mortality risk in patients with acute myocardial infarction: results from China Acute Myocardial Infarction Registry
por: Lv, Junxing, et al.
Publicado: (2023)

Current Status and Hospital-Level Differences in Care and Outcomes of Patients With Acute Non-ST-Segment Elevation Myocardial Infarction in China: Insights From China Acute Myocardial Infarction Registry
por: Zhao, Qinghao, et al.
Publicado: (2022)

Contemporary Status of Acute Myocardial Infarction in Korean Patients: Korean Registry of Acute Myocardial Infarction for Regional Cardiocerebrovascular Centers
por: Kim, Rock Bum, et al.
Publicado: (2021)

Contemporary Management of Cardiogenic Shock Complicating Acute Myocardial Infarction
por: De Luca, Leonardo, et al.
Publicado: (2023)

The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers
por: Iborra-Egea, Oriol, et al.
Publicado: (2022)

Meta-Analysis of Placebo-Controlled Trials of Levosimendan in Acute Myocardial Infarction
por: Tumminello, Gabriele, et al.
Publicado: (2021)

Exploring Sex Differences of Beta-Blockers in the Treatment of Hypertension: A Systematic Review and Meta-Analysis
por: Wilmes, Nick, et al.
Publicado: (2023)

Due caution using early β-blockers for acute myocardial infarction
por: McKee, Scott, et al.
Publicado: (2007)

Simple risk score based on the China Acute Myocardial Infarction registry for predicting in-hospital mortality among patients with non-ST-segment elevation myocardial infarction: results of a prospective observational cohort study
por: Song, Chenxi, et al.
Publicado: (2019)

Fibrinolytic therapy use for ST-segment elevation myocardial infarction and long-term outcomes in China: 2-year results from the China Acute Myocardial Infarction Registry
por: Wu, Chao, et al.
Publicado: (2023)

Association between smoking and in-hospital mortality in patients with acute myocardial infarction: results from a prospective, multicentre, observational study in China
por: Song, Chenxi, et al.
Publicado: (2019)

Effect of Beta Blockers and Renin–Angiotensin System Inhibitors on Survival in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Lee, Pil Hyung, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kjgodgm2r9hvj3u9uj63m31qr1